1Research Unit Molecular Immune Regulation, Molecular Targets and Therapeutics Center, Helmholtz Zentrum München, Munich, Germany
2Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3Institute for Immunology, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried, Germany
4Institute of Structural Biology, Molecular Targets and Therapeutics Center, Helmholtz Zentrum München, Neuherberg, Germany
5Technical University of Munich, TUM School of Natural Sciences, Department of Bioscience and Bavarian NMR Center (BNMRZ), Garching, Germany
6Max Planck Institute for Multidisciplinary Sciences, Bioanalytical Mass Spectrometry, Göttingen, Germany
7Institute of Developmental Genetics, Helmholtz Zentrum München, Neuherberg, Germany
8Department of Pathology, New York University, Grossman School of Medicine, New York, NY USA
9Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA USA
10Institute for Molecular Biology, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried, Germany
11Monoclonal Antibody Core Facility, German Research Center for Environmental Health, Neuherberg, Germany
12Research Unit Type 1 Diabetes Immunology, Helmholtz Diabetes Center at Helmholtz Zentrum München, Neuherberg, Germany
13German Center for Diabetes Research (DZD), Neuherberg, Germany
14Division of Clinical Pharmacology, Department of Medicine IV, Ludwig-Maximilians-Universität München, Munich, Germany
15Max von Pettenkofer Institute, Faculty of Medicine, Ludwig-Maximilians-Universität in Munich, Munich, Germany
16Institute of Molecular Biology (IMB), Mainz, Germany
17Chair of Developmental Genetics, Munich School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany
18Munich Cluster of Systems Neurology (SyNergy), Munich, Germany
19German Center for Neurodegenerative Diseases (DZNE) site Munich, Munich, Germany
20University Medical Center Göttingen, Department of Clinical Chemistry, Bioanalytics Group, Göttingen, Germany
21Göttingen Center for Molecular Biosciences, Georg-August University Göttingen, Göttingen, Germany
22Cluster of Excellence ‘Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells’ (MBExC), University of Göttingen, Göttingen, Germany
23Institute for Molecular Health Sciences, ETH Zürich, Zürich, Switzerland
24Institute for Integrative Neuroanatomie, Charite-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
25Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany
26Present Address: Cancer Immunology and Immune Modulation, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany
27Present Address: Repertoire Immune Medicines (Switzerland) AG, Schlieren, Switzerland